Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumors
Study Number: 

PH 281716

Phase: 
3
Trial categories: 
Lung
Principal Investigator: